Annals of clinical and laboratory science
-
Ann. Clin. Lab. Sci. · May 2020
ReviewCoagulation Panel in Patients with SARS-CoV2 Infection (COVID-19).
The 2019 novel coronavirus (SARS-CoV2) is the causal agent of the newly-termed Coronavirus Disease 2019 (COVID-19). In January 2020, the World Health Association (WHO) declared the CO-VID-19 as an epidemic. Abnormal coagulation parameters in COVID-19 patients currently are considered as prognostic factors of severity. Our aim is to summarize the current data available in the literature.